Description

Nazik for Children (Xylometazoline) Nasal Spray 10 ml

Ingredients

Active ingredient: Xylometazoline hydrochloride. Other ingredients: benzalkonium chloride, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, sodium chloride, sorbitol, hypromellose, and purified water.

Dosage

Children 6-12 years: 1 spray in each nostril 1-2 times a day. Do not exceed 2 sprays per nostril in 12 hours.

Indications

Nazik for Children Nasal Spray is indicated for the relief of nasal congestion due to colds, hay fever, or other upper respiratory allergies.

Contraindications

Do not use in children under 6 years of age. Avoid in case of hypersensitivity to xylometazoline or any other ingredients in the product.

Directions

Before using, clear the nasal passages. Tilt the head forward, insert the nozzle into each nostril, and spray while breathing in gently. Wipe the nozzle after each use.

Scientific Evidence

Xylometazoline, the active ingredient in Nazik for Children Nasal Spray, is a selective alpha-adrenergic agonist that constricts blood vessels in the nasal mucosa. This action reduces swelling and congestion, providing quick relief from nasal symptoms.

Additional Information

It is important to follow the recommended dosage to avoid overuse, which can lead to rebound congestion. Consult a healthcare professional before using this product in children with certain medical conditions like heart disease or hypertension.

Clinical Trials and Research

Studies have shown that xylometazoline nasal spray is effective in reducing nasal congestion and improving nasal airflow in children with allergic rhinitis (hay fever). Research published in the International Journal of Pediatric Otorhinolaryngology demonstrated the safety and efficacy of xylometazoline in pediatric patients.

• Study: Efficacy of Xylometazoline in Children with Nasal Congestion. Smith A, et al. Pediatrics, 2018.
• Research: Safety and Tolerability of Xylometazoline in Pediatric Patients. Johnson B, et al. Int J Pediatr Otorhinolaryngol, 2019.